Olanzapine orodispersible tablet 5 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Olanzapine orodispersible tablet 5 mg, covering 2012-01-05 to 2012-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition [Phase 1]